Green Cross-MSD’s strengthened bond in vaccine through co-promotion for ‘Gardasil’
On the 19th, Green Cross(CEO Eun-Cheol Huh) announced a co-promotion agreement of the MSD’s singles vaccine and cervical cancer, ‘Zostavax’ and ‘Gardasil & Gardasil 9,’ with MSD Korea on the 18th.
Under the agreement, Green Cross and MSD Korea will jointly promote and market ‘Zostavax’ and ‘Gard...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
